Bandingkan Harga & Kinerja Destinasi Tirta Nusantara Tbk (PDES) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Destinasi Tirta Nusantara Tbk dan Organon Pharma Indonesia Tbk.: Destinasi Tirta Nusantara Tbk diperdagangkan di Rp384 (kapitalisasi pasar 275,99 M, volume 24 jam 77,3 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Destinasi Tirta Nusantara Tbk jauh lebih besar — sekitar 2,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PDES | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 275,99 M | 104,4 M |
Volume | 77,3 rb | — |
Lot | 773 | — |
Perputaran | 29,21 jt | — |
Harga Rata-rata | 377,92 | — |
Nilai Transaksi | 29,21 jt | — |
Harga Ekuilibrium Indikatif | 384 | — |
Volume Ekuilibrium Indikatif | 200 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Destinasi Tirta Nusantara Tbk
PT Destinasi Tirta Nusantara Tbk (the company) was established on 30 Oct 1999 based on Notaries Deed No. 36 and the deed of establishment was approved by the the Ministry of Justice dated Feb 23, 2000. The Company’s articles of association has been amended several times, most recently by notarial deed No. 187 and No.136 of Wijanto Suwongso, S.H., dated Jun 28, 2007 and 24 Oct 07, concerning among others, increase authorized, Paid up Capital, par value and public offering.
Selengkapnya di halaman PDES →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
